Profund Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$936K Sell
2,419
-48
-2% -$17.8K 0.03% 366
2026
Q1
$722K Sell
2,467
-1,148
-32% -$377K 0.03% 440
2025
Q4
$1.27M Buy
3,615
+712
+25% +$241K 0.04% 292
2025
Q3
$938K Buy
2,903
+19
+0.7% +$5.91K 0.03% 344
2025
Q2
$1.12M Sell
2,884
-288
-9% -$116K 0.04% 279
2025
Q1
$1.38M Sell
3,172
-92
-3% -$36.9K 0.06% 235
2024
Q4
$1.2M Sell
3,264
-578
-15% -$242K 0.04% 264
2024
Q3
$2M Buy
3,842
+309
+9% +$165K 0.08% 187
2024
Q2
$1.91M Sell
3,533
-61
-2% -$32.2K 0.07% 183
2024
Q1
$1.86M Sell
3,594
-424
-11% -$211K 0.07% 182
2023
Q4
$1.89M Buy
4,018
+367
+10% +$170K 0.08% 183
2023
Q3
$1.59M Sell
3,651
-127
-3% -$57.6K 0.09% 178
2023
Q2
$1.68M Buy
3,778
+61
+2% +$28.1K 0.09% 178
2023
Q1
$1.71M Sell
3,717
-31
-0.8% -$14.8K 0.11% 165
2022
Q4
$1.92M Buy
3,748
+55
+1% +$27.9K 0.12% 153
2022
Q3
$1.68M Sell
3,693
-294
-7% -$141K 0.12% 154
2022
Q2
$1.92M Sell
3,987
-509
-11% -$252K 0.12% 152
2022
Q1
$2.21M Sell
4,496
-438
-9% -$200K 0.09% 180
2021
Q4
$2.29M Buy
4,934
+127
+3% +$53.4K 0.07% 189
2021
Q3
$1.79M Buy
4,807
+12
+0.3% +$4.56K 0.06% 241
2021
Q2
$1.83M Buy
4,795
+34
+0.7% +$13K 0.06% 238
2021
Q1
$1.71M Sell
4,761
-337
-7% -$108K 0.07% 222
2020
Q4
$1.64M Sell
5,098
-150
-3% -$46K 0.07% 226
2020
Q3
$1.41M Sell
5,248
-1,300
-20% -$350K 0.07% 219
2020
Q2
$1.72M Buy
6,548
+1,600
+32% +$427K 0.1% 184
2020
Q1
$1.12M Sell
4,948
-2,288
-32% -$624K 0.08% 217
2019
Q4
$2.19M Buy
7,236
+800
+12% +$220K 0.1% 187
2019
Q3
$1.54M Sell
6,436
-983
-13% -$269K 0.08% 241
2019
Q2
$2.09M Sell
7,419
-1,446
-16% -$395K 0.1% 189
2019
Q1
$2.54M Buy
8,865
+654
+8% +$189K 0.12% 148
2018
Q4
$2.16M Sell
8,211
-2,339
-22% -$643K 0.13% 141
2018
Q3
$2.89M Buy
10,550
+2,805
+36% +$728K 0.11% 161
2018
Q2
$1.84M Sell
7,745
-803
-9% -$186K 0.07% 222
2018
Q1
$1.88M Sell
8,548
-452
-5% -$106K 0.07% 221
2017
Q4
$2.02M Sell
9,000
-2,951
-25% -$629K 0.08% 236
2017
Q3
$2.27M Buy
11,951
+919
+8% +$175K 0.09% 189
2017
Q2
$2.08M Buy
11,032
+464
+4% +$83.4K 0.09% 185
2017
Q1
$1.75M Buy
10,568
+627
+6% +$99.7K 0.08% 230
2016
Q4
$1.43M Sell
9,941
-164
-2% -$22K 0.07% 263
2016
Q3
$1.27M Sell
10,105
-812
-7% -$105K 0.06% 295
2016
Q2
$1.43M Sell
10,917
-1,157
-10% -$158K 0.07% 246
2016
Q1
$1.68M Sell
12,074
-1,615
-12% -$216K 0.09% 190
2015
Q4
$1.91M Sell
13,689
-1,986
-13% -$274K 0.09% 172
2015
Q3
$2.19M Sell
15,675
-5,906
-27% -$888K 0.13% 118
2015
Q2
$3.54M Buy
21,581
+1,450
+7% +$232K 0.15% 95
2015
Q1
$3.11M Buy
20,131
+261
+1% +$37.2K 0.12% 120
2014
Q4
$2.5M Buy
19,870
+3,122
+19% +$386K 0.1% 160
2014
Q3
$2M Buy
16,748
+1,618
+11% +$186K 0.09% 189
2014
Q2
$1.63M Sell
15,130
-2,533
-14% -$261K 0.07% 281
2014
Q1
$1.76M Buy
17,663
+2,462
+16% +$223K 0.08% 215
2013
Q4
$1.4M Buy
15,201
+15
+0.1% +$1.33K 0.06% 313
2013
Q3
$1.27M Buy
15,186
+651
+4% +$55.8K 0.07% 303
2013
Q2
$1.19M Buy
+14,535
New +$1.09M 0.08% 220

Other funds holding ELV

Profund Advisors's ELV Position: Q2 2026 in Review

Profund Advisors reduced its Elevance Health (ELV) stake by 1.9% in Q2 2026, selling an estimated $17.8K and leaving 2,419 shares worth $936K. The position accounts for 0.03% of the portfolio, ranked #366.

Profund Advisors first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.54M in Q2 2015. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Profund Advisors held 2,419 shares of Elevance Health worth $936K as of Q2 2026.
  • Profund Advisors sold 48 Elevance Health shares in Q2 2026, an estimated $17.8K.
  • Elevance Health made up 0.03% of Profund Advisors's portfolio in Q2 2026, its #366 holding.
  • Profund Advisors first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • Profund Advisors's Elevance Health position peaked at $3.54M in Q2 2015.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Profund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.